Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.

Abstract

Recently we reported that resveratrol (trans-3,4',5-trihydroxystilbene) showed selective inhibition of recombinant human cytochrome P450 (P450) 1A1 in a concentration-dependent manner. The inhibition of recombinant human P450 1A1, 1A2, or 1B1 by various hydroxystilbene compounds having a similar structure to resveratrol was investigated using bacterial membranes from a human P450/NADPH-P450 reductase bicistronic expression system to find new candidates for cancer chemopreventive agents. Of seven compounds tested, rhapontigenin (3,3',5-trihydroxy-4'-methoxystilbene) exhibited a potent and selective inhibition of human P450 1A1 with an IC50 value of 0.4 microM. Rhapontigenin showed 400-fold selectivity for P450 1A1 over P450 1A2 and 23-fold selectivity for P450 1A1 over P450 1B1. Rhapontigenin did not show any significant inhibition of ethoxyresorufin O-deethylation (EROD) activity in human liver microsomes, the other human P450s such as P450 2E1, P450 3A4, P450 2D6, P450 2C8, and P450 2C9, or human NADPH-P450 reductase. We have further investigated the inhibition kinetics of P450 1A1 by rhapontigenin. Rhapontigenin inhibited EROD activity of expressed human P450 1A1 in a competitive manner. The loss of EROD activity was time- and concentration-dependent. The values for K(i) and k(inactivation) were 0.09 microM and 0.06 min(-1), respectively. The loss was not blocked by the trapping agents glutathione, N-acetylcysteine, or dithiothreitol. These results suggest that rhapontigenin is a potent mechanism-based inactivator of human P450 1A1 and may be considered as a good candidate for a cancer chemopreventive agent in humans.

• Authors: Y J Chun, S Y Ryu, T C Jeong, M Y Kim
• Journal: Drug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) Vol. 29 Issue 4 Pt 1 Pg. 389-93 (Apr 2001) ISSN: 0090-9556 [Print] United States
• PMID: 11259321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Enzyme Inhibitors
• Recombinant Proteins
• Stilbenes
• rhapontigenin
• NADP
• Cytochrome P-450 CYP1A1

Topics

• Cytochrome P-450 CYP1A1 (antagonists & inhibitors, genetics, metabolism)
• Enzyme Inhibitors (pharmacology)
• Humans
• In Vitro Techniques
• Kinetics
• Microsomes, Liver (drug effects, metabolism)
• NADP (metabolism)
• Recombinant Proteins (antagonists & inhibitors, metabolism)
• Stilbenes (pharmacology)